PFE : Summary for Pfizer, Inc. Common Stock - Yahoo Finance

U.S. Markets closed

Pfizer Inc. (PFE)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
34.06+0.47 (+1.40%)
At close: 4:00PM EST

34.00 -0.06 (-0.18%)
After hours: 6:21PM EST

People also watch
MRKJNJJPMGEINTC
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close33.59
Open33.70
Bid0.00 x
Ask0.00 x
Day's Range33.58 - 34.12
52 Week Range28.74 - 37.39
Volume30,476,794
Avg. Volume25,539,378
Market Cap206.69B
Beta1.02
PE Ratio (TTM)29.04
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.28 (3.81%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • American City Business Journals54 minutes ago

    United Therapeutics feels squeeze from increased pulmonary hypertension competition

    United Therapeutics Corp. (UTHR) blames increasing competition in the pulmonary arterial hypertension space for its lower-than-expected revenue last year, CEO Martine Rothblatt told analysts Wednesday. During the Silver Spring-based company's fourth-quarter earnings call, Rothblatt said there has been weaker growth for some of its drugs — Orenitram, Tyvaso and Remodulin. Patients are sticking with alternative therapies, such as a combination of Adcirca with Letairis, longer than expected before switching to its products, she said.

  • MarketWatch2 hours ago

    Dow logs 10th straight record, but Nasdaq stumbles a second day

    U.S. stocks retreat modestly on Thursday, pulling back from intraday records as technology stocks struggle amid persistent concerns about lofty valuations and the prospects for fiscal stimulus a day after ...

  • Business Wire2 hours ago

    Ronald E. Blaylock Elected to Pfizer’s Board of Directors

    Pfizer Inc. today announced the election of Ronald E. Blaylock to its Board of Directors, effective immediately. Mr. Blaylock was also appointed to the Corporate Governance and Science and Technology Committees of Pfizer’s Board.